BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26138387)

  • 1. Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study.
    Mantel Ä; Holmqvist M; Nyberg F; Tornling G; Frisell T; Alfredsson L; Askling J
    Arthritis Rheumatol; 2015 Nov; 67(11):2845-54. PubMed ID: 26138387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis.
    Westerlind H; Rönnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson PJ; Skriner K; Klareskog L; Saevarsdottir S; Askling J
    Arthritis Rheumatol; 2020 Oct; 72(10):1658-1667. PubMed ID: 32475073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis.
    Ljung L; Rantapää-Dahlqvist S; Jacobsson LT; Askling J
    Ann Rheum Dis; 2016 Dec; 75(12):2087-2094. PubMed ID: 26984007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis.
    Ljung L; Simard JF; Jacobsson L; Rantapää-Dahlqvist S; Askling J;
    Arthritis Rheum; 2012 Jan; 64(1):42-52. PubMed ID: 21898355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study.
    Bird P; Nicholls D; Barrett R; de Jager J; Griffiths H; Roberts L; Tymms K; McCloud P; Littlejohn G;
    Int J Rheum Dis; 2017 Apr; 20(4):460-468. PubMed ID: 28205333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age.
    Frisell T; Holmqvist M; Källberg H; Klareskog L; Alfredsson L; Askling J
    Arthritis Rheum; 2013 Nov; 65(11):2773-82. PubMed ID: 23897126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks.
    Holmqvist M; Ljung L; Askling J
    Ann Rheum Dis; 2017 Oct; 76(10):1642-1647. PubMed ID: 28710095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis.
    Bos WH; Bartelds GM; Wolbink GJ; de Koning MH; van de Stadt RJ; van Schaardenburg D; Dijkmans BA; Nurmohamed MT
    J Rheumatol; 2008 Oct; 35(10):1972-7. PubMed ID: 18785316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
    Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
    Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome.
    Westerlind H; Holmqvist M; Ljung L; Frisell T; Askling J
    Ann Rheum Dis; 2019 May; 78(5):683-687. PubMed ID: 30787006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
    de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF
    Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice.
    Neovius M; Simard JF; Klareskog L; Askling J;
    Ann Rheum Dis; 2011 Aug; 70(8):1407-14. PubMed ID: 21518724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis.
    Meissner Y; Zink A; Kekow J; Rockwitz K; Liebhaber A; Zinke S; Gerhold K; Richter A; Listing J; Strangfeld A
    Arthritis Res Ther; 2016 Aug; 18(1):183. PubMed ID: 27495156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.
    Ajeganova S; Andersson ML; Frostegård J; Hafström I
    J Rheumatol; 2013 Dec; 40(12):1958-66. PubMed ID: 23950188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: a simple model of prediction from a conservatively treated community-based inception cohort.
    Le Loët X; Brazier M; Mejjad O; Boumier P; Daragon A; Gayet A; Pouplin S; Tron F; Zarnitsky C; Vittecoq O; Menard JF; Fardellone P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1739-47. PubMed ID: 20740612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis.
    Evans MR; Escalante A; Battafarano DF; Freeman GL; O'Leary DH; del Rincón I
    Arthritis Rheum; 2011 May; 63(5):1211-20. PubMed ID: 21305526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum 14-3-3η is a novel marker that complements current serological measurements to enhance detection of patients with rheumatoid arthritis.
    Maksymowych WP; Naides SJ; Bykerk V; Siminovitch KA; van Schaardenburg D; Boers M; Landewé R; van der Heijde D; Tak PP; Genovese MC; Weinblatt ME; Keystone EC; Zhukov OS; Abolhosn RW; Popov JM; Britsemmer K; van Kuijk AW; Marotta A
    J Rheumatol; 2014 Nov; 41(11):2104-13. PubMed ID: 25128504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis.
    Nyhäll-Wåhlin BM; Petersson IF; Nilsson JA; Jacobsson LT; Turesson C;
    Rheumatology (Oxford); 2009 Apr; 48(4):416-20. PubMed ID: 19213849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease.
    Machold KP; Stamm TA; Eberl GJ; Nell VK; Dunky A; Uffmann M; Smolen JS
    J Rheumatol; 2002 Nov; 29(11):2278-87. PubMed ID: 12415582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.